Found: 83
Select item for more details and to access through your institution.
Integrated stress response and immune cell infiltration in an ibrutinib‐refractory mantle cell lymphoma patient following ONC201 treatment.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 133, doi. 10.1111/bjh.15271
- By:
- Publication type:
- Article
Frontline antibiotic therapy for early‐stage Helicobacter pylori‐negative gastric MALT lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E150, doi. 10.1002/ajh.25447
- By:
- Publication type:
- Article
Immunotherapy in mantle cell lymphoma: Anti-CD20-based therapy and beyond.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 2, p. 144, doi. 10.1002/ajh.21036
- By:
- Publication type:
- Article
Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 8, p. 725, doi. 10.1002/ajh.20852
- By:
- Publication type:
- Article
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0191461
- By:
- Publication type:
- Article
Update of the M. D. Anderson Cancer Center Experience with Hyper-CVAD and Rituximab for the Treatment of Mantle Cell and Burkitt-Type Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 8, p. S57
- By:
- Publication type:
- Article
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. 1, doi. 10.1186/s13046-018-0800-9
- By:
- Publication type:
- Article
Smoldering mantle cell lymphoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0652-8
- By:
- Publication type:
- Article
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 15, doi. 10.1016/j.clml.2012.09.009
- By:
- Publication type:
- Article
Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings.
- Published in:
- Modern Pathology, 2004, v. 17, n. 5, p. 553, doi. 10.1038/modpathol.3800068
- By:
- Publication type:
- Article
Real-Time RT-PCR Assay for Quantifying Cyclin D1 mRNA in B-Cell Non-Hodgkin’s Lymphomas.
- Published in:
- Modern Pathology, 2002, v. 15, n. 5, p. 556, doi. 10.1038/modpathol.3880562
- By:
- Publication type:
- Article
Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 2, p. 243, doi. 10.1111/bjh.12003
- By:
- Publication type:
- Article
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 1, p. 47, doi. 10.1111/j.1365-2141.2010.08315.x
- By:
- Publication type:
- Article
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 2, p. 200, doi. 10.1111/j.1365-2141.2010.08228.x
- By:
- Publication type:
- Article
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 3, p. 355, doi. 10.1111/j.1365-2141.2008.07353.x
- By:
- Publication type:
- Article
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 3, p. 439, doi. 10.1111/j.1365-2141.2006.06457.x
- By:
- Publication type:
- Article
Frontline Treatment for Older Patients with Mantle Cell Lymphoma.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1337, doi. 10.1634/theoncologist.2017-0470
- By:
- Publication type:
- Article
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 549, doi. 10.1634/theoncologist.2016-0328
- By:
- Publication type:
- Article
Nuclear Translocation of B-Cell-Specific Transcription Factor, BACH2, Modulates ROS Mediated Cytotoxic Responses in Mantle Cell Lymphoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0069126
- By:
- Publication type:
- Article
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. e94, doi. 10.1111/bjh.16378
- By:
- Publication type:
- Article
Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 670, doi. 10.1111/bjh.15814
- By:
- Publication type:
- Article
Integrated stress response and immune cell infiltration in an ibrutinib‐refractory mantle cell lymphoma patient following ONC201 treatment.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 133, doi. 10.1111/bjh.15271
- By:
- Publication type:
- Article
A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 460, doi. 10.1111/bjh.15107
- By:
- Publication type:
- Article
Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 578, doi. 10.1111/bjh.15567
- By:
- Publication type:
- Article
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 404, doi. 10.1111/bjh.15411
- By:
- Publication type:
- Article
Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 561, doi. 10.1111/bjh.14669
- By:
- Publication type:
- Article
Dose adjusted- EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 503, doi. 10.1111/bjh.14226
- By:
- Publication type:
- Article
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R- FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 263, doi. 10.1111/bjh.14541
- By:
- Publication type:
- Article
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 750, doi. 10.1111/bjh.14477
- By:
- Publication type:
- Article
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 290, doi. 10.1111/bjh.14237
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 463, doi. 10.1111/bjh.13603
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 814, doi. 10.1111/bjh.13367
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 177, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Current regimens and novel agents for mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 1, p. 3, doi. 10.1111/bjh.13000
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 112, doi. 10.1111/bjh.12715
- By:
- Publication type:
- Article
Prospective phase II study of rituximab with alternating cycles of hyper- CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 611, doi. 10.1111/bjh.12585
- By:
- Publication type:
- Article
Long term results of a phase 2 study of vincristine sulfate liposome injection ( Marqibo<sup>®</sup>) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non- Hodgkin lymphomas
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 631, doi. 10.1111/bjh.12446
- By:
- Publication type:
- Article
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 1, p. 138, doi. 10.1111/bjh.12326
- By:
- Publication type:
- Article